Skip to content

SimExpr2SampleData

Institute Provider

Università di Padova

Primary Contact name

Available versions

1.0

Topics

Description

Methodologies for the discovery of biomarkers related to diseases using microarray data often provide limited results, due to the dataset size, the heterogeneity of the disease and the heterogeneity of experimental protocols and computational pipelines employed in the analysis. Focusing on the first two issues, a simulation schema was developed to outline advantages and drawbacks of classification and feature selection methods on a benchmark with known biomarkers.

Development stage

---

Licence

---

Cost

---

Accessibility

---

Sign Up and Start Learning

We are using cookies to give you the best experience - Read our privacy Policy